PLRAX
Price
$7.18
Change
+$0.03 (+0.42%)
Updated
Jun 18 closing price
Net Assets
2.23B
VBLIX
Price
$10.46
Change
+$0.04 (+0.38%)
Updated
Jun 18 closing price
Net Assets
8.55B
Interact to see
Advertisement

PLRAX vs VBLIX

PLRAX vs VBLIX Comparison Chart in %
View a ticker or compare two or three
VS
PLRAX vs. VBLIX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRAX is a Hold and VBLIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VBLIX has more cash in the bank: 8.55B vs. PLRAX (2.24B). VBLIX pays higher dividends than PLRAX: VBLIX (4.79) vs PLRAX (4.31). PLRAX was incepted earlier than VBLIX: PLRAX (9 years) vs VBLIX (15 years). PLRAX (4.29) is less costly to investors than VBLIX (0.02). PLRAX is a more actively managed with annual turnover of: 206.00 vs. VBLIX (24.00). PLRAX has a lower initial minimum investment than VBLIX: PLRAX (1000) vs VBLIX (100000000). PLRAX annual gain was more profitable for investors over the last year : 6.74 vs. VBLIX (0.87). PLRAX return over 5 years is better than : -18.88 vs. VBLIX (-33.50).
PLRAXVBLIXPLRAX / VBLIX
Total Expense Ratio4.290.0221,450%
Annual Report Gross Expense Ratio4.290.0221,450%
Fund Existence9 years15 years-
Gain YTD0.452-1.419-32%
Front Load4%N/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.24B8.55B26%
Annual Yield % from dividends4.314.7990%
Returns for 1 year6.740.87774%
Returns for 3 years8.99-7.54-119%
Returns for 5 years-18.88-33.5056%
Returns for 10 yearsN/A-20.65-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GBLCX42.05-0.27
-0.64%
American Funds Global Balanced C
KLCSX19.63-0.15
-0.76%
Federated Hermes Kaufmann Large Cap R6
HFMCX21.17-0.19
-0.89%
Hartford MidCap A
VRMGX39.54-0.65
-1.62%
Virtus KAR Mid-Cap Growth R6
PZVMX12.94-0.31
-2.34%
Pzena Mid Cap Value Investor